CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia

PHASE1RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
B-cell Acute Lymphocytic Leukemia
Interventions
BIOLOGICAL

CD19 CAR-T cells

CNS leukemia is defined as unequivocal evidence of leukemic blasts in the cerebrospinal fluid by cytology or flow cytometry; cranial palsies or a nonhemorrhagic mass seen in cranial computed tomography or magnetic resonance imaging because of infiltration by leukemia cells

Trial Locations (1)

Unknown

RECRUITING

The First Affiliated Hospital of Soochow University, Suzhou

All Listed Sponsors
collaborator

The First Affiliated Hospital of Soochow University

OTHER

lead

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd

INDUSTRY